Giede-Jeppe, Antje
Atay, Selim
Koehn, Julia
Mrochen, Anne
Luecking, Hannes
Hoelter, Philip
Volbers, Bastian
Huttner, Hagen B.
Hueske, Lena
Bobinger, Tobias
Article History
Received: 2 December 2020
Accepted: 17 May 2021
First Online: 31 May 2021
Competing interests
: Dr. Giede-Jeppe reports no disclosures. Mr. Atay reports no disclosures. Dr. Koehn reports no disclosures. Dr. Mrochen reports no disclosures. Dr. Luecking reports no disclosures. Dr. Hoelter reports no disclosures. Dr. Volbers reports personal fees from Pfizer AG/Bristol-Myers Squibb SA, personal fees from Bayer AG, grants from Institutional grant (Inselspital), personal fees from Ipsen Pharma, personal fees from CSL Behring, outside the submitted work. Prof. Huttner reports research grants by Novartis, Medtronic, UCB Pharma and Portola Pharmaceuticals. HBH reports personal fees from Bayer AG, Boehringer Ingelheim, Daiichi Sankyo, Medtronic, CLS Behring, UCB Pharma and Portola Pharmaceuticals. Dr. Hueske reports no disclosures. Dr. Bobinger reports no disclosures.